Multiply £126 by 300,000 and the answer is £37.8m. Against a £40m headline figure, the numbers appear remarkably neat. But behind the arithmetic lies a more uncomfortable question, did the patients come first, or did the funding envelope? The distinction matters because the winter prevention programme announced this week by the Prime Minister and the Health Secretary will be judged not only by its ability to keep patients out of hospital, but also by what it demands of the general practices expected to deliver it.
The mechanics are straightforward. Primary care networks (PCNs) can claim £126 for every eligible patient they support, with up to 300,000 people covered by the scheme. Practices will identify those most at risk of becoming seriously unwell over winter, including people living with frailty, heart disease and chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD). They will then offer proactive health checks and medication reviews, alongside nurse-led respiratory clinics for patients who need them. Andy Burnham acknowledged that the NHS should not expect an easy winter, while Yvette Cooper pointed to the considerable pressure placed on health services during the summer by extreme heat. The initiative forms part of a wider package that includes the flu vaccination programme and additional urgent care capacity.
The clinical case is difficult to dispute. Frail older people and those living with advanced respiratory disease account for a disproportionate share of winter emergency admissions. A timely medication review or an early assessment of worsening respiratory symptoms in a familiar GP surgery can cost a fraction of a hospital stay. Reaching someone before a persistent cough becomes an ambulance call is precisely the sort of intervention a winter plan should prioritise. General practice, with its knowledge of patients and their medical histories, is the natural place to deliver it.
The financial arrangements, however, are considerably less reassuring. The £40m is not new money. It is being reallocated from existing GP budgets for 2026-27, with trade reporting tracing the funding to income removed from practices through NHS England's list validation programme. The BMA has said that more than 300,000 patients were removed from practice lists between June 2025 and June 2026, resulting in the loss of just under £40m in core funding. A specialist medical accountant has observed that the winter scheme will not restore the full amount, while requiring practices to undertake additional work with money they had previously expected to receive. Funding that was once predictable, because it followed registered patients, has become conditional: practices must now deliver specified activity within a limited winter window, with payments channelled through networks rather than necessarily returning to the practices that lost the income.
The unit payment makes the tension harder to ignore. On the BMA's figures, baseline funding for a patient's care works out at approximately 36p a day, or around £131 over a year. The proposed winter payment of £126 therefore comes close to the amount a practice receives for a full year of ordinary care for one patient. Yet this payment is intended to cover additional work for some of the frailest and most medically complex people on the practice list, compressed into just a few winter months. That may be sufficient if much of the work is already taking place and simply needs to be better organised and recorded. It looks considerably less generous if medication reviews, home assessments and respiratory clinics require substantial additional clinical time from a workforce already struggling to keep pace with demand.
The real test will come when PCNs attempt to turn the announcement into appointments, assessments and treatment. Patients must first be identified and risk-stratified. Clinicians must then be found to carry out reviews, while respiratory testing requires trained staff and appropriate equipment. All this must happen in the weeks before winter pressures reach their peak. Clinical directors will have to weigh the promised payment against the capacity lost when nurses and GPs are diverted from routine services. Integrated care boards, already operating under considerable financial constraints, will want evidence that the scheme reduces admissions in measurable terms. Hospital trusts, meanwhile, will be looking for signs that any benefit reaches emergency departments before January. Without a clear baseline showing admission rates among the targeted patients, the evaluation expected in spring risks becoming a matter of competing interpretations rather than a settled verdict.
The political calculation is not difficult to read. A government under pressure to demonstrate that it is preparing the NHS for winter, but with little room for additional public spending, has found a measure that can be presented as a £40m intervention without requiring fresh money from the Treasury. That is understandable as a matter of fiscal management, but it leaves the programme open to criticism. If general practice is told it is receiving support through money drawn from its own existing contract, the credibility of that promise will depend on whether patients and clinicians experience a genuine improvement. A programme presented as investment but experienced as a transfer risks reinforcing a damaging perception of what the state is prepared to fund.
The Royal College of GPs has long argued that continuity of care for people with complex needs depends on sustained investment, and that short-term seasonal initiatives cannot substitute for it. That argument is difficult to dismiss. Prevention is not an occasional winter expense, frailty and chronic respiratory disease do not begin or end with the financial year. The immediate test of this scheme will come in March, when admission figures become available. But the more consequential verdict will be delivered when the next GP contract is negotiated. If the £40m becomes a precedent for repeatedly redirecting existing practice budgets, general practice will have little reason to regard the scheme as genuine support. If, instead, it becomes a recurring commitment backed by new funding, this winter's programme may prove to be the beginning of something more substantial.
